Analysis of NK cell phenotype showed a reduction of immature CD56bright NK cells (Fig. 1b), and a parallel enrichment in the mature (CD56dim/CD57+) subset (Fig. 1c) in patients with COVID-19 compared with healthy controls. This evidence concerns the gene B3GAT1 and COVID-19.